Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Editas Medicine Inc (NASDAQ: EDIT) closed at $2.44 down -2.79% from its previous closing price of $2.51. In other words, the price has decreased by -$2.79 from its previous closing price. On the day, 1.62 million shares were traded. EDIT stock price reached its highest trading level at $2.49 during the session, while it also had its lowest trading level at $2.37.
Ratios:
For a deeper understanding of Editas Medicine Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.08 and its Current Ratio is at 3.08. In the meantime, Its Debt-to-Equity ratio is 0.50 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on April 28, 2025, initiated with a Buy rating and assigned the stock a target price of $3.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 31 ’25 when Burkly Linda bought 7,500 shares for $3.46 per share.
Parison Amy sold 446 shares of EDIT for $769 on Jun 03 ’25. The SVP, Chief Financial Officer now owns 17,506 shares after completing the transaction at $1.72 per share. On Jun 03 ’25, another insider, Burkly Linda, who serves as the EVP, CHIEF SCIENTIFIC OFFICER of the company, sold 726 shares for $1.72 each. As a result, the insider received 1,252 and left with 69,519 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EDIT now has a Market Capitalization of 204259472 and an Enterprise Value of 14428376. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.70 while its Price-to-Book (P/B) ratio in mrq is 3.27. Its current Enterprise Value per Revenue stands at 0.403 whereas that against EBITDA is -0.072.
Stock Price History:
The Beta on a monthly basis for EDIT is 2.20, which has changed by -0.48414373 over the last 52 weeks, in comparison to a change of 0.20277917 over the same period for the S&P500. Over the past 52 weeks, EDIT has reached a high of $5.45, while it has fallen to a 52-week low of $0.91. The 50-Day Moving Average of the stock is 3.21%, while the 200-Day Moving Average is calculated to be 25.40%.
Shares Statistics:
For the past three months, EDIT has traded an average of 2.53M shares per day and 2648380 over the past ten days. A total of 83.71M shares are outstanding, with a floating share count of 82.95M. Insiders hold about 0.91% of the company’s shares, while institutions hold 54.48% stake in the company. Shares short for EDIT as of 1752537600 were 8516241 with a Short Ratio of 3.37, compared to 1749772800 on 8426415. Therefore, it implies a Short% of Shares Outstanding of 8516241 and a Short% of Float of 10.2.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
